1189TiP Phase II study of anti-TIGIT GSK4428859A (GSK’859A)/EOS-448 + anti-CD96 GSK6097608 (GSK’608) + anti-PD-1 dostarlimab in non-small cell lung cancer (NSCLC)
- Resource Type
- Source
- Annals of Oncology. 33:S1092
- Subject
Oncology Hematology - Language
- ISSN
- 0923-7534